Mycobacterium tuberculosis Sigma Factor E Regulon Modulates the Host Inflammatory Response

Fontán, Patricia A.; Aris, Virginie; Alvarez, María E.; Ghanny, Saleena; Cheng, Jeff; Soteropoulos, Patricia; Trevani, Analia; Pine, Richard; Smith, Issar
September 2008
Journal of Infectious Diseases;9/15/2008, Vol. 198 Issue 6, p877
Academic Journal
Mycobacterium tuberculosis survives in macrophages and usually subverts the bactericidal mechanisms of these phagocytes. The understanding of this host-pathogen interaction is relevant for the development of new treatments for tuberculosis. The adaptation of M. tuberculosis to intracellular life depends on its ability to regulate the expression of its genes. Sigma factors are important bacterial transcription activators that bind to the RNA polymerase and give it promoter specificity. Sigma factor E (SigE) controls the expression of genes that are essential for virulence. We have identified the SigE regulon during infection of macrophages, and we analyzed the impact of this regulon on the transcriptional response of phagocytes. Our results indicate that SigE regulates the expression of genes involved in the maintenance of M. tuberculosis cell envelope integrity and function during macrophage infection. Analysis of the phagocytes' transcriptional response indicates that the SigE regulon is involved in the modulation of the inflammatory response.


Related Articles

  • Functional Genetic Diversity among Mycobacterium tuberculosis Complex Clinical Isolates: Delineation of Conserved Core and Lineage-Specific Transcriptomes during Intracellular Survival. Homolka, Susanne; Niemann, Stefan; Russell, David G.; Rohde, Kyle H. // PLoS Pathogens;Jul2010, Vol. 6 Issue 7, p1 

    Tuberculosis exerts a tremendous burden on global health, with ~9 million new infections and ~2 million deaths annually. The Mycobacterium tuberculosis complex (MTC) was initially regarded as a highly homogeneous population; however, recent data suggest the causative agents of tuberculosis are...

  • The Past and Future of Tuberculosis Research. Comas, Iñaki; Gagneux, Sebastien // PLoS Pathogens;Oct2009, Vol. 5 Issue 10, p1 

    Renewed efforts in tuberculosis (TB) research have led to important new insights into the biology and epidemiology of this devastating disease. Yet, in the face of the modern epidemics of HIV/AIDS, diabetes, and multidrug resistance-all of which contribute to susceptibility to TB-global control...

  • Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosis. Hasan, Samiul; Daugelat, Sabine; Rao, P. S. Srinivasa; Schreiber, Mark // PLoS Computational Biology;Jun2006, Vol. 2 Issue 6, pe61 

    We have developed a software program that weights and integrates specific properties on the genes in a pathogen so that they may be ranked as drug targets. We applied this software to produce three prioritized drug target lists for Mycobacterium tuberculosis, the causative agent of...

  • CLINICAL AND BIOLOGICAL PROFILE OF MYCOBACTERIUM TUBERCULOSIS (MTB) - A REVIEW. Raghvendra; Saraswathi, R. // International Journal of Pharmaceutical Sciences Review & Resear;Jul/Aug2012, Vol. 15 Issue 2, p99 

    Tuberculosis, MTB, or TB is a common, and in many cases lethal, infectious disease caused by various strains of mycobacteria, usually Mycobacterium tuberculosis. Tuberculosis typically attacks the lungs but can also affect other parts of the body. It is spread through the air when people who...

  • Airborne Severe Acute Respiratory Syndrome Coronavirus and Its Implications. Tong, Tommy R. // Journal of Infectious Diseases;5/1/2005, Vol. 191 Issue 9, p1401 

    The article informs that airborne transmission of the severe acute respiratory syndrome (SARS) coronavirus (CoV) has been the favored explanation for its transmission on an aircraft and appeared to explain a large community outbreak of SARS in the Amoy Gardens in Hong Kong. Several viruses and...

  • Tuberculous Effusion Development in a Patient with Sarcoidosis During Corticosteroid Therapy. Yanarda, Halil; G�ne, Yilmaz // Internet Journal of Pulmonary Medicine;2003, Vol. 3 Issue 1, p50 

    A 47-year-old man was diagnosed as Löfgren's syndrome and corticosteroid therapy was started. On the seventh month of therapy a pleural effusion developed. Although no definite diagnosis could be made, anti-tuberculous therapy was started empirically. Three weeks later mycobacterium growth...

  • Mechanism of Inducible Nitric Oxide Synthase Exclusion from Mycobacterial Phagosomes. Davis, Alexander S.; Vergne, Isabelle; Master, Sharon S.; Kyei, George B.; Chua, Jennifer; Deretic, Vojo // PLoS Pathogens;Dec2007, Vol. 3 Issue 12, pe186 

    Mycobacterium tuberculosis is sensitive to nitric oxide generated by inducible nitric oxide synthase (iNOS). Consequently, to ensure its survival in macrophages, M. tuberculosis inhibits iNOS recruitment to its phagosome by an unknown mechanism. Here we report the mechanism underlying this...

  • Paleopathology of Human Tuberculosis and the Potential Role of Climate. Nerlich, Andreas G.; Lösch, Sandra // Interdisciplinary Perspectives on Infectious Diseases;2009, p1 

    Both origin and evolution of tuberculosis and its pathogens (Mycobacterium tuberculosis complex) are not fully understood. The paleopathological investigation of human remains offers a unique insight into the molecular evolution and spread including correlative data of the environment....

  • PhoP: A Missing Piece in the Intricate Puzzle of Mycobacterium tuberculosis Virulence. Gonzalo-Asensio, Jesús; Mostowy, Serge; Harders-Westerveen, Jose; Huygen, Kris; Hernández-Pando, Rogelio; Thole, Jelle; Behr, Marcel; Gicquel, Brigitte; Martín, Carlos // PLoS ONE;2008, Vol. 3 Issue 10, p1 

    Inactivation of the transcriptional regulator PhoP results in Mycobacterium tuberculosis attenuation. Preclinical testing has shown that attenuated M. tuberculosis phoP mutants hold promise as safe and effective live vaccine candidates. We focused this study to decipher the virulence networks...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics